Atomistry » Zinc » PDB 3gtv-3h68 » 3gwt
Atomistry »
  Zinc »
    PDB 3gtv-3h68 »
      3gwt »

Zinc in PDB 3gwt: Catalytic Domain of Human Phosphodiesterase 4B2B in Complex with A Quinoline Inhibitor

Enzymatic activity of Catalytic Domain of Human Phosphodiesterase 4B2B in Complex with A Quinoline Inhibitor

All present enzymatic activity of Catalytic Domain of Human Phosphodiesterase 4B2B in Complex with A Quinoline Inhibitor:
3.1.4.17;

Protein crystallography data

The structure of Catalytic Domain of Human Phosphodiesterase 4B2B in Complex with A Quinoline Inhibitor, PDB code: 3gwt was solved by D.O.Somers, M.Neu, with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:

Resolution Low / High (Å) 20.00 / 1.75
Space group I 21 21 21
Cell size a, b, c (Å), α, β, γ (°) 88.706, 94.783, 105.995, 90.00, 90.00, 90.00
R / Rfree (%) 20.5 / 25

Other elements in 3gwt:

The structure of Catalytic Domain of Human Phosphodiesterase 4B2B in Complex with A Quinoline Inhibitor also contains other interesting chemical elements:

Magnesium (Mg) 1 atom
Arsenic (As) 5 atoms

Zinc Binding Sites:

The binding sites of Zinc atom in the Catalytic Domain of Human Phosphodiesterase 4B2B in Complex with A Quinoline Inhibitor (pdb code 3gwt). This binding sites where shown within 5.0 Angstroms radius around Zinc atom.
In total only one binding site of Zinc was determined in the Catalytic Domain of Human Phosphodiesterase 4B2B in Complex with A Quinoline Inhibitor, PDB code: 3gwt:

Zinc binding site 1 out of 1 in 3gwt

Go back to Zinc Binding Sites List in 3gwt
Zinc binding site 1 out of 1 in the Catalytic Domain of Human Phosphodiesterase 4B2B in Complex with A Quinoline Inhibitor


Mono view


Stereo pair view

A full contact list of Zinc with other atoms in the Zn binding site number 1 of Catalytic Domain of Human Phosphodiesterase 4B2B in Complex with A Quinoline Inhibitor within 5.0Å range:
probe atom residue distance (Å) B Occ
A:Zn504

b:22.0
occ:1.00
 NE2 A:HIS238 2.1 19.7 1.0
O A:HOH74 2.1 26.2 1.0
NE2 A:HIS274 2.1 17.2 1.0
OD2 A:ASP275 2.2 19.6 1.0
O A:HOH523 2.2 20.3 0.7
OD1 A:ASP392 2.2 18.5 1.0
CD2 A:HIS274 3.0 17.0 1.0
CD2 A:HIS238 3.1 15.6 1.0
CG A:ASP392 3.1 24.5 1.0
CE1 A:HIS238 3.1 15.5 1.0
CG A:ASP275 3.1 14.8 1.0
CE1 A:HIS274 3.1 22.9 1.0
OD2 A:ASP392 3.3 25.4 1.0
OD1 A:ASP275 3.7 17.9 1.0
MG A:MG505 3.8 27.1 1.0
AS A:ARS4 3.9 29.9 0.3
CG A:HIS274 4.2 17.7 1.0
CD2 A:HIS234 4.2 21.2 1.0
ND1 A:HIS274 4.2 20.0 1.0
O A:HOH78 4.2 26.3 1.0
ND1 A:HIS238 4.2 21.1 1.0
CG A:HIS238 4.2 16.8 1.0
CB A:ASP275 4.3 15.0 1.0
O A:HOH522 4.3 22.5 1.0
CB A:ASP392 4.4 20.4 1.0
NE2 A:HIS234 4.5 22.3 1.0
CG2 A:VAL242 4.7 19.2 1.0
O A:HOH75 4.9 24.1 1.0
CA A:ASP392 4.9 21.1 1.0

Reference:

M.D.Woodrow, S.P.Ballantine, M.D.Barker, B.J.Clarke, J.Dawson, T.W.Dean, C.J.Delves, B.Evans, S.L.Gough, S.B.Guntrip, S.Holman, D.S.Holmes, M.Kranz, M.K.Lindvaal, F.S.Lucas, M.Neu, L.E.Ranshaw, Y.E.Solanke, D.O.Somers, P.Ward, J.O.Wiseman. Quinolines As A Novel Structural Class of Potent and Selective PDE4 Inhibitors. Optimisation For Inhaled Administration. Bioorg.Med.Chem.Lett. V. 19 5261 2009.
ISSN: ISSN 0960-894X
PubMed: 19656678
DOI: 10.1016/J.BMCL.2009.04.012
Page generated: Thu Oct 24 14:02:55 2024

Last articles

Mg in 1XNG
Mg in 1XN0
Mg in 1XMY
Mg in 1XMV
Mg in 1XMX
Mg in 1XMI
Mg in 1XMU
Mg in 1XM6
Mg in 1XMJ
Mg in 1XM4
© Copyright 2008-2020 by atomistry.com
Home   |    Site Map   |    Copyright   |    Contact us   |    Privacy